Sooah Cho

Partner

Sooah joined SignalFire in 2023 as a Partner focused on investments in early-stage health and life sciences tech. Prior to SignalFire, she was a product leader at CVS Health, where she launched nationwide prescription delivery and virtual care products, and Devoted Health, currently valued at over $12 billion.

At Underscore VC, she invested in fast-growing B2B software startups, including life sciences tech products used by leading biopharma companies across the drug development cycle from R&D to commercial stages. She began her career at Michael Porter’s strategy firm where she advised healthcare & biopharma executives.

Sooah has a joint-degree MBA | MPP from Harvard Business School and Harvard Kennedy School, where she worked with startup founders at the HBS Rock Center for Entrepreneurship and built her digital health investment thesis as a Rock Venture Partner with Bain Capital.

As a product builder, GTM strategist, and policy nerd turned investor, she partners with founders at the earliest stages of their discovery, building, and scaling journey. She’s excited to reimagine how we develop, deliver, & pay for healthcare today and usher in a new era of AI-enabled health and longevity for all.

Sooah Cho

Sooah Cho's Posts

February 10, 2026

Why we invested in Solace: Making healthcare advocacy a standard of care

SignalFire is doubling down on Solace’s $130 million Series C. Discover how Solace uses a full-stack OS and CMS reimbursement (CHI/PIN codes) to turn healthcare advocacy into essential infrastructure, achieving 10x YoY growth and a $1 billion+ valuation.

Read more

October 7, 2025

Why we invested in Peer AI’s agentic backbone for the next era of drug approvals

SignalFire backs Peer AI, an agentic AI platform that accelerates life-sciences regulatory writing, reduces errors, and speeds therapies to patients.

Read more

August 28, 2025

AI agents are rewriting biopharma’s $140B playbook - ending manual, outsourced drug development

AI agents are disrupting biopharma’s $140B outsourcing model, replacing manual CRO/CDMO workflows with faster, cheaper, and more compliant automation.

Read more

June 25, 2025

Mandolin lands $40M to accelerate access to life-saving specialty drugs with AI agent platform

Mandolin raises $40M to bring AI automation to specialty drug access by streamlining referral-to-reimbursement workflows for infusion centers and specialty pharmacies.

Read more

February 12, 2025

Justpoint raises $95M to tackle the toxic exposure epidemic with AI

Discover how Justpoint, backed by $95 million in new funding, uses AI to detect hidden dangers in products and pharmaceuticals, leading the fight against toxic exposure.

Read more

January 8, 2025

SignalFire’s big bet on Qualified Health: Transforming healthcare with responsible AI

Qualified Health is redefining AI adoption in healthcare by prioritizing safety, governance, and scalability. SignalFire is proud to lead Qualified Health’s $30M seed round, partnering with a visionary team tackling some of the biggest hurdles in AI adoption.

Read more

August 29, 2024

The business-in-a-box model: Grow Therapy’s playbook

A look at how Grow Therapy used the business-in-a-box model to build trust, expand, and scale quickly

Read more

July 17, 2024

Funding Freshpaint's $30M Series B for HIPAA-compliant healthcare marketing

It’s illegal to use Facebook ads, Google Analytics, or YouTube to market many healthcare services if you don’t follow strict privacy laws.

Read more

December 18, 2023

The pharma fast lane: How software will speed up drug development

A guide to the biggest opportunities for pharma software startups to improve drug discovery, clinical studies, and commercialization.

Read more

September 5, 2023

Sooah Cho joins SignalFire as Partner for Health and Life Sciences Tech

Sooah Cho joins SignalFire as a Partner to fund and support the most audacious founders building in health and life sciences tech.

Read more